ArticleCase reports in dentistry2026
Treatment of Obstructive Sleep Apnea With Mandibular Advancement Device (MAD) in a 58-year-old Female Patient With Psychiatric Comorbidity: Case Report With 6-Month Follow-up.
Article in Case reports in dentistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obstructive sleep apnea (OSA) and major depressive disorder frequently coexist, creating a complex bidirectional relationship that influences diagnosis and treatment adherence. Continuous positive airway pressure (CPAP) remains the gold standard for OSA treatment; however, poor tolerance or refusal is common, particularly among patients with psychiatric comorbidities. Case Report: A case of a 58-year-old female patient with moderate OSA and major depressive disorder who declined CPAP therapy due to psychological discomfort is presented. Following multidisciplinary evaluation, a mandibular advancement device (MAD) was implemented as an alternative treatment. Over a 6-month follow-up, significant improvements were observed in OSA severity and depressive symptoms, including increased oxygen saturation, reduced apneic events, and enhanced mood, despite stable pharmacological treatment. Conclusions: This case demonstrates the clinical effectiveness of MADs in managing OSA in patients intolerant to CPAP, especially those with psychiatric comorbidities. The importance of interdisciplinary collaboration in the management of complex cases is also emphasized.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.